Pembrolizumab improves OS in firstline treatment for unresectable advanced pleural mesothelioma

Dr Penelope Bradbury - Princess Margaret Cancer Centre, Toronto, Canada
Pembrolizumab improves OS in firstline treatment for unresectable advanced pleural mesothelioma ( Dr Penelope Bradbury - Princess Margaret Cancer Centre, Toronto, Canada )
4 Jun 2023

Pembro plus chemo followed by resection and adjuvant pembro improves on standard of care for early NSCLC

Prof Heather Wakelee - Stanford Cancer Institute, Stanford, USA
Pembro plus chemo followed by resection and adjuvant pembro improves on standard of care for early NSCLC ( Prof Heather Wakelee - Stanford Cancer Institute, Stanford, USA )
4 Jun 2023

Tackling low-volumes of clinical trials in Africa

Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria
Tackling low-volumes of clinical trials in Africa ( Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria )
25 May 2023

The HypoAfrica study and AC3T research partnerships at NLCC

Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria
The HypoAfrica study and AC3T research partnerships at NLCC ( Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria )
17 May 2023

Achieving health equity in cancer care in the Philippines

Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The Philippines
Achieving health equity in cancer care in the Philippines ( Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The Philippines )
10 May 2023

Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC

Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC ( Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain )
26 Apr 2023

Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma

Prof Peter Szlosarek - Barts Cancer Institute, London, UK
Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma ( Prof Peter Szlosarek - Barts Cancer Institute, London, UK )
26 Apr 2023

To avoid unnecessary second surgery in differentiated thyroid cancer

Dr Thou Sarameth - Calmette Hospital, Phnom Penh, Cambodia
To avoid unnecessary second surgery in  differentiated thyroid cancer ( Dr Thou Sarameth - Calmette Hospital, Phnom Penh, Cambodia )
25 Apr 2023

Key practices for handling difficult conversations in cancer care

Dr Madelaine Amurao-Amante - Philippine Society of Medical Oncology, Manila, Philippines
Key practices for handling difficult conversations in cancer care ( Dr Madelaine Amurao-Amante - Philippine Society of Medical Oncology, Manila, Philippines )
19 Apr 2023

Choosing wisely in complementary treatment for cancer in the Philippines

Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital, Dagupan City, Philippines
Choosing wisely in complementary treatment for cancer in the Philippines ( Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital, Dagupan City, Philippines )
19 Apr 2023

Indications for the appropriate use of a PET-CT scan for common cancers

Dr Jonas Santiago - St Luke's Medical Center, Manila, Philippines
Indications for the appropriate use of a PET-CT scan for common cancers ( Dr Jonas Santiago - St Luke's Medical Center, Manila, Philippines )
19 Apr 2023

A multidisciplinary team approach to cancer care in the Philippines

Dr Arnold John Uson - Perpetual Succour Hospital of Cebu, Cebu, Philippines
A multidisciplinary team approach to cancer care in the Philippines ( Dr Arnold John Uson - Perpetual Succour Hospital of Cebu, Cebu, Philippines )
12 Apr 2023